In vitro and in vivo testing methods for respiratory drug delivery

被引:41
作者
Agu, Remigius U. [1 ]
Ugwoke, Michael I. [2 ]
机构
[1] Dalhousie Univ, Coll Pharm, Fac Hlth Profess, Biopharmaceut & Drug Delivery Lab, Halifax, NS B3H 3J5, Canada
[2] Nanomi BV, NL-7575 EJ Oldenzaal, Netherlands
关键词
cell culture; drug testing methods; in vitro; in vivo; inhalation aerosol; respiratory drug delivery; EPITHELIAL-CELL MONOLAYERS; PARTICLE-SIZE; SYSTEMIC DELIVERY; CASCADE IMPACTOR; LUNG; PULMONARY; INHALER; AEROSOL; DISSOLUTION; ABSORPTION;
D O I
10.1517/17425247.2011.543896
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Importance of the field: Successful respiratory drug delivery for local and systemic purposes is predicated on the availability of in vitro and in vivo methods for determining drug delivery and disposition following respiratory administration. Areas covered in this review: In this review, the relevance of new in vitro and in vivo methods for screening respiratory drug delivery is discussed. Specific topics covered include in vitro particle size characterization, in vitro dissolution test methods for respiratory formulations and in vitro respiratory absorption and disposition screening methods. Furthermore, in vivo respiratory dosing methods, in vivo respiratory aerosol deposition and drug absorption screening methods, and correlation between in vitro and in vivo methods are reviewed. What the reader will gain: After reading this article, the reader will have an enriched knowledge regarding the various in vitro and in vivo testing methods for respiratory drug delivery. Most importantly, this paper will make it possible for readers to appreciate the strengths and weaknesses of each test method, which in turn will assist them in selecting specific methods that suit their scientific needs. Take home message: New in vitro and in vivo methods for screening respiratory drug delivery are indispensible, especially from the respiratory drug development and quality control perspective. Each method has unique advantages and disadvantages that influence method selection and data interpretation. Although in vitro methods are used during drug development, they augment rather than substitute in vivo methods.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 102 条
[1]
Agu RU, 2001, RESP RES, V2, P198
[3]
Application of in vitro dissolution tests to different uranium compounds and comparison with in vivo data [J].
Ansoborlo, E ;
Guilmette, RA ;
Hoover, MD ;
Chazel, V ;
Houpert, P ;
Henge-Napoli, MH .
RADIATION PROTECTION DOSIMETRY, 1998, 79 (1-4) :33-37
[4]
Factors affecting bronchodilator delivery in mechanically ventilated adults [J].
Ari, Arzu ;
Fink, James B. .
NURSING IN CRITICAL CARE, 2010, 15 (04) :192-203
[5]
In Vitro Aqueous Fluid-Capacity-Limited Dissolution Testing of Respirable Aerosol Drug Particles Generated from Inhaler Products [J].
Arora, Deepika ;
Shah, Kumar A. ;
Halquist, Matthew S. ;
Sakagami, Masahiro .
PHARMACEUTICAL RESEARCH, 2010, 27 (05) :786-795
[6]
Permeability issues in nasal drug delivery [J].
Arora, P ;
Sharma, S ;
Garg, S .
DRUG DISCOVERY TODAY, 2002, 7 (18) :967-975
[7]
BAO D, 2010, PHARM RES
[8]
BERUBE K, 2010, TOXICOLOGY
[9]
Beyssac E., 2005, DISSOLUT TECHNOL, V12, P23
[10]
Minimizing variability of cascade impaction measurements in inhalers and nebulizers [J].
Bonam, Matthew ;
Christopher, David ;
Cipolla, David ;
Donovan, Brent ;
Goodwin, David ;
Holmes, Susan ;
Lyapustina, Svetlana ;
Mitchell, Jolyon ;
Nichols, Steve ;
Pettersson, Gunilla ;
Quale, Chris ;
Rao, Nagaraja ;
Singh, Dilraj ;
Tougas, Terrence ;
Van Oort, Mike ;
Walther, Bernd ;
Wyka, Bruce .
AAPS PHARMSCITECH, 2008, 9 (02) :404-413